Insilico Medicine

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Last updated Aug 30, 2026

Website

2014Active285Hong Kong, China

About

Insilico Medicine is a generative AI company focused on transforming drug discovery and development. They utilize proprietary AI platforms like PandaOmics and Chemistry42 to discover novel therapeutic targets and generate new molecular structures, aiming to extend healthy productive longevity.

Key facts

At-a-glance profile data

Website: insilico.com
Headquarters: Hong Kong, China
Founded: 2014
Employees: 285
Total funding: -
Business model: B2B

Tech stack

Detected on insilico.com, last scanned 24 Sept 2026. Run your own scan

Analytics: Google Analytics 4
CDN: Cloudflare
Email provider: Google Workspace

Add first review

Frequently asked

How many employees does Insilico Medicine have?

Insilico Medicine has approximately 285 people on record.